Next Century Growth Investors’s Ligand Pharmaceuticals LGND Stock Holding History

Next Century Growth Investors’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$62.8M	Buy	198,542 +102,666	+107%	+$24.2M	3.33%	2
2026 Q1	$19.1M	Buy	+95,876	New	+$19M	1.39%	27
2019 Q3	–	Sell	-66,239	Closed	-$4.72M	–	133
2019 Q2	$4.72M	Sell	66,239 -1,704	-3%	-$126K	0.59%	56
2019 Q1	$5.33M	Sell	67,943 -34,021	-33%	-$2.58M	0.71%	56
2018 Q4	$8.63M	Buy	101,964 +29,255	+40%	+$3.12M	1.23%	23
2018 Q3	$12.4M	Sell	72,709 -10,988	-13%	-$1.66M	1.44%	14
2018 Q2	$10.8M	Sell	83,697 -6,134	-7%	-$684K	1.38%	21
2018 Q1	$9.26M	Sell	89,831 -44,199	-33%	-$4.37M	1.23%	31
2017 Q4	$11.4M	Sell	134,030 -10,484	-7%	-$909K	1.42%	25
2017 Q3	$12.3M	Sell	144,514 -47,907	-25%	-$3.79M	1.47%	20
2017 Q2	$14.6M	Sell	192,421 -37,132	-16%	-$2.6M	1.4%	23
2017 Q1	$15.2M	Sell	229,553 -40,854	-15%	-$2.69M	1.28%	21
2016 Q4	$17.1M	Buy	270,407 +2,684	+1%	+$169K	1.05%	33
2016 Q3	$17M	Sell	267,723 -28,646	-10%	-$2.1M	0.78%	44
2016 Q2	$22.1M	Sell	296,369 -208,352	-41%	-$15.5M	1.03%	29
2016 Q1	$33.7M	Buy	504,721 +141,013	+39%	+$8.57M	1.59%	21
2015 Q4	$24.6M	Buy	363,708 +17,338	+5%	+$1.07M	1.06%	28
2015 Q3	$18.5M	Buy	346,370 +84,271	+32%	+$5.11M	0.77%	43
2015 Q2	$16.5M	Sell	262,099 -251,231	-49%	-$13.7M	0.57%	56
2015 Q1	$24.7M	Sell	513,330 -166,866	-25%	-$6.39M	0.87%	32
2014 Q4	$22.6M	Sell	680,196 -103,044	-13%	-$3.35M	0.81%	42
2014 Q3	$23M	Buy	783,240 +369,908	+89%	+$12.3M	0.81%	42
2014 Q2	$16.1M	Sell	413,332 -247,033	-37%	-$10M	0.52%	65
2014 Q1	$27.7M	Sell	660,365 -32,931	-5%	-$1.37M	0.82%	40
2013 Q4	$22.7M	Sell	693,296 -29,203	-4%	-$951K	0.63%	56
2013 Q3	$19.5M	Buy	722,499 +556,340	+335%	+$15.7M	0.56%	53
2013 Q2	$3.88M	Buy	+166,159	New	+$2.99M	0.12%	148

Other funds holding LGND

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Next Century Growth Investors's LGND Position: Q2 2026 in Review

Next Century Growth Investors increased its Ligand Pharmaceuticals (LGND) stake by 107% in Q2 2026, buying an estimated $24.2M and bringing the position to 198,542 shares worth $62.8M. The position accounts for 3.33% of the portfolio, ranked #2.

Next Century Growth Investors first reported a position in LGND in Q2 2013 and has held it in 27 quarters since. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

Next Century Growth Investors held 198,542 shares of Ligand Pharmaceuticals worth $62.8M as of Q2 2026.
Next Century Growth Investors bought 102,666 Ligand Pharmaceuticals shares in Q2 2026, an estimated $24.2M.
Ligand Pharmaceuticals made up 3.33% of Next Century Growth Investors's portfolio in Q2 2026, its #2 holding.
Next Century Growth Investors first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 27 quarters since.
416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Next Century Growth Investors's 13F filing for Q2 2026, filed 14 Aug 2026.